With Japan facing increasing pressure to balance healthcare affordabilitywith innovation, challenges such as drug lag and pricing policies are more critical than ever. As the global pharmaceutical landscape evolves and healthcare demands grow and technological advancements accelerate, Japan must navigate these issues to remain competitive and foster advancements in healthcare.
The BCCJ invites you to a timely lunchtime event on Thursday, February 6 at the AstraZeneca KK office, examining the current and future state of drug development and approval in Japan, and how this compares to the UK. Our panel of experts will explore how regulatory frameworks, innovation ecosystems, public-private partnerships, and international collaboration can address these pressing challenges and unlock new opportunities.
This event is designed for industry professionals, policymakers, researchers, and anyone interested in the future of healthcare in Japan and synergies in healthcare innovation between Japan and the UK.
